| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |


From the Division of Comparative Medicine,* Massachusetts Institute of Technology, Cambridge, Massachusetts; the University of Massachusetts Medical Center,
Worcester, Massachusetts; and Columbia University,
New York, New York
Trefoil factor family 2 (TFF2) is up-regulated in Helicobacter spp.-infected gastric tissues of both humans and mice. To ascertain the biological effects of TFF2 in vivo, TFF2–/– C57BL/6 x Sv129 and wild-type (WT) C57BL/6 x Sv129 mice were orally infected with Helicobacter pylori SS1. Mice were evaluated for gastric H. pylori colonization, pathology, and cytokine profiles at 6 and 19 months post inoculation (pi). At 6 months pi, there was a significant difference (P < 0.05) for epithelial criteria (mucosal defects, atrophy, hyperplasia, pseudopyloric metaplasia, and dysplasia) in the corpus of TFF2–/– versus WT mice. At 19 months pi, a similar statistical difference in epithelial parameters was noted in the antrum of TFF2–/– versus WT mice (P < 0.01). All of the TFF2–/– H. pylori-infected mice had high-grade antral dysplasia, including gastric intraepithelial neoplasia, which was statistically significant (P < 0.05) compared with the infected WT mice. Levels of interferon-
were markedly elevated in the gastric mucosa of infected TFF2–/– mice at both 6 and 19 months pi. TFF2 provided a cytoprotective and/or anti-inflammatory effect against the progression of premalignant lesions of the gastric corpus at 6 months pi and in the pyloric antrum in H. pylori-infected mice at 19 months pi. These data support a protective role for TFF2 in part by modulating levels of gastric interferon-
in the development of H. pylori-associated premalignancy of the distal stomach.
This article has been cited by other articles:
![]() |
S. P. Tu, A. L. Chi, W. Ai, S. Takaishi, Z. Dubeykovskaya, M. Quante, J. G. Fox, and T. C. Wang p53 inhibition of AP1-dependent TFF2 expression induces apoptosis and inhibits cell migration in gastric cancer cells Am J Physiol Gastrointest Liver Physiol, August 1, 2009; 297(2): G385 - G396. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takaishi, S. Tu, Z. A. Dubeykovskaya, M. T. Whary, S. Muthupalani, B. H. Rickman, A. B. Rogers, N. Lertkowit, A. Varro, J. G. Fox, et al. Gastrin Is an Essential Cofactor for Helicobacter-Associated Gastric Corpus Carcinogenesis in C57BL/6 Mice Am. J. Pathol., July 1, 2009; 175(1): 365 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Lemke, Z. Ge, M. T. Whary, Y. Feng, A. B. Rogers, S. Muthupalani, and J. G. Fox Concurrent Helicobacter bilis Infection in C57BL/6 Mice Attenuates Proinflammatory H. pylori-Induced Gastric Pathology Infect. Immun., May 1, 2009; 77(5): 2147 - 2158. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Dubeykovskaya, A. Dubeykovskiy, J. Solal-Cohen, and T. C. Wang Secreted Trefoil Factor 2 Activates the CXCR4 Receptor in Epithelial and Lymphocytic Cancer Cell Lines J. Biol. Chem., February 6, 2009; 284(6): 3650 - 3662. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-W. Lee, B. Rickman, A. B. Rogers, Z. Ge, T. C. Wang, and J. G. Fox Helicobacter pylori Eradication Prevents Progression of Gastric Cancer in Hypergastrinemic INS-GAS Mice Cancer Res., May 1, 2008; 68(9): 3540 - 3548. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |